Table 6.

Adverse events with brivaracetam treatment

Patients with adverse events
Na	877
n (%)	264 (30.1)
Most frequently reported adverse events (reported by ≥ 1% of patients)
Na	852
Somnolence	56 (6.6)
Nervousness and/or agitation	50 (5.9)
Vertigo	31 (3.6)
Fatigue	26 (3.1)
Headache	22 (2.6)
Aggressiveness	20 (2.3)
Mood change	20 (2.3)
Dizziness	19 (2.2)
Sleep disturbances	15 (1.8)
Memory disturbance	14 (1.6)

Data are expressed as n (%)

AEs reported by fewer than 1% of patients: nausea/vomiting, tremor (all n = 8, 0.9%), stomach pain (n = 7, 0.8%), disturbances in attention/concentration (n = 6, 0.7%), anxiety, diplopia/blurred vision (all n = 5, 0.6%), weight increase (n = 4, 0.5%), skin disorders, hair loss (all n = 3, 0.4%), fever, pharyngodynia, hyporexia (all n = 2, 0.2%), urinary disturbances, weight decrease, psychosis, tics, confusion, acouphene, constipation, abdominal pain (all n = 1, 0.1%)

^aN represents the total number of patients for whom the data in question were available